Rashi Pharmaceuticals Private Limited

Manufactures and markets medical, pharmaceutical, and orthopedic goods and healthcare products.

2004 | Lucknow, Uttar Pradesh (India) | Active
Last Updated:

Rashi Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 21 Year, 28 Days
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 32.63%
  • Profit Growth 89.09%
  • Ebitda 23.64%
  • Net Worth 63.35%
  • Total Assets 10.49%

About Rashi Pharmaceuticals

Rashi Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 February 2004 and has a history of 21 years. Its registered office is in Lucknow, Uttar Pradesh, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Mahesh Bhatnagar, Rana Bhatnagar, and Madhu Bhatnagar serve as directors at the Company.

Company Details

  • Location

    Lucknow, Uttar Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U51397UP2004PTC028301

  • Company No.

    028301

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    13 Feb 2004

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kanpur

Industry

Healthcare
Company report

Rashi Pharmaceuticals Private Limited

Explore comprehensive data for Rashi Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Rashi Pharmaceuticals?

Board Members (3)

NameDesignationAppointment DateStatus
Mahesh Bhatnagar Country flag representing In Director 13-Feb-2004Current
Rana Bhatnagar Country flag representing In Director 13-Feb-2004Current
Madhu Bhatnagar Country flag representing In Director 13-Feb-2004Current

Financial Performance of Rashi Pharmaceuticals.

Rashi Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.63% increase. The company also saw a substantial improvement in profitability, with a 89.09% increase in profit. The company's net worth Soared by an impressive increase of 63.35%.

Rashi Pharmaceuticals revenue growth over time
Rashi Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
32.63%
Revenue from Operations
32.63%
Total Assets
10.49%
Profit or Loss
89.09%
Net Worth
63.35%
EBITDA
23.64%

What is the Ownership and Shareholding Structure of Rashi Pharmaceuticals?

In 2021, Rashi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Rashi Pharmaceuticals?

Unlock and access historical data on people associated with Rashi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Rashi Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rashi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rashi Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Rashi Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Rashi Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Rashi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.

  • Director Appointment

    Mahesh Singh Bhatnagar was appointed as a Director was appointed as a Director on 13 Feb 2004 & has been associated with this company since 21 years 28 days .

  • Director Appointment

    Rana Bhatnagar was appointed as a Director was appointed as a Director on 13 Feb 2004 & has been associated with this company since 21 years 28 days .

  • Director Appointment

    Madhu Bhatnagar was appointed as a Director was appointed as a Director on 13 Feb 2004 & has been associated with this company since 21 years 28 days .

  • Company Incorporation

    Rashi Pharmaceuticals Private Limited was registered on 13 Feb 2004 with Roc Kanpur & aged 21 years 28 days as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Rashi Pharmaceuticals Private Limited?

    Rashi Pharmaceuticals Private Limited was incorporated on 13 Feb 2004.

  • What is authorized share capital and paid-up capital of Rashi Pharmaceuticals Private Limited?

    The authorized share capital of Rashi Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Rashi Pharmaceuticals Private Limited?

    Currently 3 directors are associated with Rashi Pharmaceuticals Private Limited.

    • Mahesh Singh Bhatnagar
    • Rana Bhatnagar
    • Madhu Bhatnagar
  • What is the registered address of Rashi Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Rashi Pharmaceuticals Private Limited is 35/2 Pandey Talab Colony Aishbagh, Lucknow India, Uttar Pradesh, 226001.

  • What is the corporate identification number (CIN) and company number of Rashi Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Rashi Pharmaceuticals Private Limited is U51397UP2004PTC028301 and the company number is 028301 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Rashi Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Rashi Pharmaceuticals Private Limited has risen by 32.63%.

  • What change has been observed in the net worth of Rashi Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Rashi Pharmaceuticals Private Limited has experienced an upsurge of 63.35%.

  • When was the last Balance Sheet of Rashi Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Rashi Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial